Literature DB >> 23297760

Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?

H Campbell1, M P Escudier, J Brostoff, P Patel, P Milligan, S J Challacombe, J D Sanderson, M C E Lomer.   

Abstract

BACKGROUND: Orofacial granulomatosis (OFG) is a chronic granulomatous condition of the mouth, face and lips. Recent work demonstrates a high rate of atopy and silver birch sensitisation from skin prick testing (SPT). Oral allergy syndrome (OAS) is an acute oro-pharyngeal IgE mediated reaction, triggered by foods that cross react with pollens, most commonly silver birch. The aim of this study was to determine if patients with OFG and positive SPT to common OAS associated pollens responded to avoidance of cross reactive foods.
METHODS: Patients with OFG and positive SPT to silver birch, grass, mugwort, ragweed and latex were required to avoid cross reacting foods, for 6 weeks and, in those who responded, for a total of 12 weeks. All had standardized oral examinations and were given severity scores (SS) at each appointment.
RESULTS: Twenty two of 47 (47%) patients had one or more positive SPT and 13/22 completed 6 weeks on the diet. No difference was seen in SS between weeks 0 (14.62 ± 11.16) and 6 (13.31 ± 10.33; P = 0.656). Six of 14 (43%) had significantly improved SS (week 0; 19.17 ± 12.95, week 6; 10.83 ± 4.99, P = 0.027). Five completed 12 weeks and no further improvement was seen (week 6; 11 ± 5.57, week 12; 10.4 ± 9.94; P = 0.068). Two patients required no further treatments.
CONCLUSIONS: On an intention to treat basis, only 2/14 patients improved and required no further intervention. Whilst this diet cannot be recommended routinely, the improvement seen in some patients raises questions about the role of OAS in patients with OFG.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Keywords:  oral allergy syndrome; orofacial granulomatosis

Mesh:

Year:  2013        PMID: 23297760     DOI: 10.1111/jop.12041

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

Review 1.  Dietary management of IBD--insights and advice.

Authors:  Emma P Halmos; Peter R Gibson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

2.  The role of exclusive enteral nutrition in the management of orofacial granulomatosis in children.

Authors:  Mohamed Mutalib; Khaled Bezanti; Mamoun Elawad; Fevronia Kiparissi
Journal:  World J Pediatr       Date:  2016-11-03       Impact factor: 2.764

Review 3.  An update on granulomatous diseases of the oral tissues.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2013-08-15

4.  Oral allergy syndrome in children.

Authors:  Irena Ivković-Jureković
Journal:  Int Dent J       Date:  2015-03-26       Impact factor: 2.607

5.  Immunophenotype in orofacial granulomatosis with and without Crohn's disease.

Authors:  Gita Gale; Sofia Ostman; Robert Saalman; Esbjörn Telemo; Mats Jontell; Bengt Hasséus
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-11-01

6.  Orofacial granulomatosis: a questionnaire study among Norwegian dental clinicians.

Authors:  A B Skaare; E S Hovden; B B Herlofson; T M Søland
Journal:  Eur Arch Paediatr Dent       Date:  2020-02-04

7.  Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease.

Authors:  Pritash Patel; Jonathan Brostoff; Helen Campbell; Rishi M Goel; Kirstin Taylor; Shuvra Ray; Miranda Lomer; Michael Escudier; Stephen Challacombe; Jo Spencer; Jeremy Sanderson
Journal:  Clin Transl Allergy       Date:  2013-08-15       Impact factor: 5.871

Review 8.  Orofacial granulomatosis and diet therapy: a review of the literature and two clinical cases.

Authors:  Iris Espinoza; Jorge Navarrete; Juana Benedetto; Arturo Borzutzky; Patricia Roessler; Ana Ortega-Pinto
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

9.  Orofacial Granulomatosis in a Child.

Authors:  Reena Razdan; Maxwell D Newby; Michele M Carr
Journal:  Case Rep Pediatr       Date:  2019-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.